Gary Pepper
Endocrinology, Diabetes & Metabolism · Jupiter, FLNPI 1881608545
Payments from drug & device makers
Across 621 payments — averaging $148.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$61K
- Acella Pharmaceuticals, LLC$11K
- AbbVie$10K
- Novo Nordisk$1K
- Sanofi-aventis U.S. LLC$1K
- Tosoh Bioscience, Inc.$1K
- plus $7K from 46 others
What the payments were for
- Consulting fees$11,24335%
- Speaking & faculty fees$9,38829%
- Food & beverage$10,10532%
- Education$750%
- Gifts$1,0783%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NP Thyroid$8,731
- Synthroid$3,600
- ARMOUR THYROID$3,150
- NP Thyroid 60$2,225
- 25-OH Vitamin D ST AIA-Pack$2,156
- TU, ST, AIA-PACK$539
- TU, AIA-PACK Calibrator Set$539
- Kerendia$144
- SOMATULINE DEPOT$125
- t-slim insulin pump$119
- AFREZZA$107
How this compares
$92,525 in reported general payments places this provider in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 11 | $18,891 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $8,484 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $7,578 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 27 | $3,068 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,883 |
| LantusInsulin Glargine,hum.Rec.Anlog | 12 | $1,676 |
| Humalog Kwikpen U-100Insulin Lispro | 12 | $1,613 |
| SynthroidLevothyroxine Sodium | 20 | $1,602 |
| Levothyroxine Sodium | 86 | $946 |
| Rosuvastatin Calcium | 22 | $392 |
| Metformin Hcl | 41 | $264 |
| Simvastatin | 11 | $212 |
| Glimepiride | 15 | $160 |
| Glipizide | 13 | $114 |
| Amlodipine Besylate | 16 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $550 | $18,89111 claims |
| Sanofi-aventis U.S. LLCLantus | $1,127 | $1,67612 claims |
| AbbVieSynthroid | $10,039 | $1,60220 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $223 | $94686 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
Other endocrinology, diabetes & metabolism in Jupiter
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
- Barry HorowitzWest Palm Beach$7.1M
- Tina ThethiOrlando$3.8M
- David SuttonJacksonville$3.1M
- Lorena Lewy-AlterbaumHollywood$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
- Rodolfo GalindoMiami$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.